Is the serum FLC assay as sensitive as IFE for detecting minimal residual disease?
Serum FLC assays are more sensitive than IFE for detecting minimal residual disease. A large subset of patients who are in complete remission (CR) by IFE have been shown to be abnormal by serum FLC assay. It has been shown that an abnormal κ/λ ratio during IFE CR is indicative of a higher risk of early relapse.